Chimerism mediated immunotherapy using Campath T cell depleted peripheral blood progenitor cells (PBPC) with nonablative therapy provides reliable, durable allogeneic engraftment.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Long, GD; Vredenburgh, JJ; Gasparetto, C; Smith, CS; Morris, AK; Petros, WP; Davis, PH; Lassiter, ME; Waters-Pick, BA; Chao, NJ

Published Date

  • November 16, 2000

Published In

Volume / Issue

  • 96 / 11

Start / End Page

  • 521A - 521A

International Standard Serial Number (ISSN)

  • 0006-4971